Hippocampal astrocyte dysfunction contributes to etomidate-induced long-lasting synaptic inhibition

Area of Science:

• Neuroscience
• Anesthesiology
• Astrocyte Biology

Background:

• General anesthetics are known to cause cognitive impairments, but the mechanisms remain unclear.
• Astrocyte dysfunction has been implicated in neurological disorders.

Purpose of the Study:

• To investigate the role of hippocampal astrocyte dysfunction in etomidate-induced long-lasting cognitive deficits.
• To elucidate the mechanisms underlying anesthetic-induced cognitive impairments.

Main Methods:

• Administration of etomidate to aged mice at different concentrations.
• Microdialysis and magnetic-activated cell sorting to assess astrocyte function.
• Designer receptors exclusively activated by designer drugs (DREADDs) to manipulate astrocyte activity.

Main Results:

• Etomidate treatment led to long-lasting cognitive deficits, synaptic inhibition, and impaired hippocampal astrocyte function, including reduced secretion of glutamate, d-serine, and ATP.
• Inhibiting hippocampal astrocytes reversed long-term cognitive and synaptic deficits.
• Activating hippocampal astrocytes with a sedative dose of etomidate induced synaptic inhibition and cognitive dysfunction.

Conclusions:

• Hippocampal astrocyte dysfunction is a key factor in maintaining synaptic inhibition following etomidate exposure.
• Astrocyte dysfunction contributes to the development of long-lasting cognitive deficits induced by general anesthetics.